In New York, she embarked upon a new career in philanthropy, sharing her husband's interest in health care and health education. She also authored one book of poetry, "My Heart Looks Up." In 1970, she met and marred New York City oil company executive, Arnold Schwartz, and left Washington and the newspaper world behind. Johnson " and "White House Brides," a history of romances and marriages in the White House involving its occupants. As an author, Marie wrote a number of books, including: "Entertaining in the White House,"which grew out of her experiences covering the White House "The President's Lady: An Intimate Biography of Mrs. She served as President of the American Newspaper Women's Club. She was cited by the National League of American Pen Women for outstanding achievement in non-fiction writing. O'Brien award for excellence in women's news reporting in a competition with 1,000 other reporters throughout the country. She was chosen "best woman writer' in Washington by the Sons and Daughters Foundation. As a journalist, Marie was a staff writer for the Washington Post from 1954 until 1970, during which years she covered the White House during the administration of four Presidents: Eisenhower, Kennedy, Johnson and Nixon. She holds an honorary doctor of humane letters degree from the Long Island University College of Pharmacy. A native of Atlanta, Georgia, Marie attended schools there and a branch of the University of Georgia system in Atlanta (now Georgia State University). She is survived by her niece, Sylvia Kerstein Kossel, and stepdaughter, Constance Schwartz Harris. She was the daughter of the late David Paul Smith and Dessie Marr Smith and a sister of the late Nellie Jane Smith Macdonald, Annie Pauline Smith, Ruth Smith Kerstein and David Porter Smith. Schwartz, journalist, author and philanthropist, died on March 15 at Greenwich Hospital, Greenwich, Connecticut, at the age of 97. SCHWARTZ, Journalist, Author, Philanthropist, 97 Marie D. Considerations for operationalizing NPK are also summarized.Įnoxaparin generic drug prices levothyroxine mometasone furoate new prior knowledge.Marie D. The paradoxical combination of "new" and "prior knowledge" is chosen deliberately to highlight both a distinction from proprietary and trade secret information and to acknowledge certain historical dogmas inherent in the current practices. The proposed NPK seeks to generate knowledge about critical aspects of pharmaceutical quality and failure modes to place it in the public domain and to facilitate accelerated and more confident development and regulatory review of generic products. The corporate economic advantages of such knowledge are derived, in part, when significant portions remain a trade secret. This knowledge is described as New Prior Knowledge (NPK) because research is often needed to fill ontological (i.e., the domain of connectivity between concepts and phenomena), epistemological (i.e., distinguishing knowledge or justified belief from the opinion), and methodological gaps in information derived a decade or so ago. This paper focuses on facilitating the utility of prior pharmaceutical formulation knowledge to accelerate drug product development and regulatory review of generic and biosimilar products. Facilitating utility of prior "Chemistry, Manufacturing, and Controls" (CMC) knowledge to accelerate new drug development and regulatory review process is also a topic of significant interest. For example, progress has been made via modeling and simulation of pharmacokinetic and pharmacodynamic relationships in the more effective use of "End of Phase 2" regulatory meetings for a New Drug Application (NDA). Facilitating utility of prior knowledge to accelerate evidence-based new drug development is a focus of several communities of knowledge, such as clinical pharmacology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |